Edition:
United Kingdom

Halozyme Therapeutics Inc (HALO.OQ)

HALO.OQ on NASDAQ Stock Exchange Global Select Market

19.87USD
23 Feb 2018
Change (% chg)

$0.59 (+3.06%)
Prev Close
$19.28
Open
$19.38
Day's High
$19.98
Day's Low
$19.31
Volume
493,702
Avg. Vol
375,709
52-wk High
$21.12
52-wk Low
$11.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 189.56 0.813
Sep '17 63.73 0.019
Jun '17 33.75 -0.230
Mar '17 29.57 -0.256
FY 2016 Dec '16 39.00 -0.214
Sep '16 31.85 -0.226
Jun '16 33.34 -0.210
Mar '16 42.50 -0.155
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 7 31.75 42.40 28.00 37.80
Quarter Ending Jun-18 7 32.40 44.40 29.00 40.40
Year Ending Dec-18 8 130.47 178.00 121.00 160.35
Year Ending Dec-19 9 190.41 306.00 140.08 201.20
Earnings (per share)
Quarter Ending Mar-18 10 -0.20 -0.13 -0.25 -0.25
Quarter Ending Jun-18 10 -0.20 -0.11 -0.26 -0.23
Year Ending Dec-18 11 -0.80 -0.24 -1.07 -0.86
Year Ending Dec-19 10 -0.51 0.01 -0.89 -0.36
LT Growth Rate (%) 1 55.00 55.00 55.00 55.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 2.08 0.90 0.89
Price to Sales (TTM) 18.15 110.72 5.77
Price to Book (MRQ) 41.87 13.56 5.41
Price to Tangible Book (MRQ) 41.87 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 86.26 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1.24 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -9.85 78.63 5.59
Sales - 5 Yr. Growth Rate 21.20 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -9.29 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -76.35 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 30.51 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.94 1.80 2.18
Current Ratio (MRQ) 4.13 5.30 2.97
LT Debt to Equity (MRQ) 284.56 22.82 12.22
Total Debt to Equity (MRQ) 362.82 24.47 16.52
Interest Coverage (TTM) -5.12 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 75.80 40.03 54.70
Gross Margin - 5 Yr. Avg. 79.63 51.06 52.42
EBITD Margin (TTM) -71.44 -- --
EBITD - 5 Yr. Avg -65.96 -572.68 10.86
Operating Margin (TTM) -73.28 -717.10 4.64
Operating Margin - 5 Yr. Avg. -67.76 -594.00 6.26
Pre-Tax Margin (TTM) -88.50 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -74.75 -597.35 6.60
Net Profit Margin (TTM) -89.43 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -75.00 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 518,046 22,602,130 855,673,508
Net Income/Employee (TTM) -463,290 2,968,748 100,656,226
Receivable Turnover (TTM) 7.12 20.14 5.78
Inventory Turnover (TTM) 2.50 2.36 3.35
Asset Turnover (TTM) 0.42 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.44 -1.05 10.98
Return on Assets - 5 Yr. Avg. -45.55 -0.57 12.37
Return on Investment (TTM) -46.20 1.66 14.43
Return on Investment - 5 Yr. Avg. -58.60 2.23 16.18
Return on Equity (TTM) -352.48 2.58 16.13
Return on Equity - 5 Yr. Avg. -332.60 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 8.61 38.85 21.20
EPS (TTM) % -216.49 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Halozyme Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 30.89 26.38 99 53
13 Week 31.70 25.28 99 62
26 Week 35.76 25.44 99 77
52 Week 41.58 20.00 99 50
YTD 73.68 52.53 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 89.76%
# of Holders: 277
Total Shares Held: 128,431,082
3 Mo. Net Change: 5,743,102
# New Positions: 56
# Closed Positions: 16
# Increased Positions: 147
# Reduced Positions: 78
# Net Buyers: 69
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.